Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 26.06
+0.56 (2.20%)
Mar 6, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.25 billion as of March 6, 2026. Its market cap has increased by 188.36% in one year.
Market Cap
5.25B
Enterprise Value
5.08B
Revenue
1.67B
Ranking
n/a
PE Ratio
21.85
Stock Price
26.06
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.25B, a decrease of -23.14%. That is a compound annual growth rate of -4.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.25B | 25.71% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.66B |
| Kexing Biopharm | 5.63B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.55B |
| PharmaResources (Shanghai) | 5.27B |
| Hangzhou Biotest Biotech | 5.10B |
| ChemPartner PharmaTech | 4.96B |
| Beijing Bohui Innovation Biotechnology Group | 4.93B |
| Assure Tech (Hangzhou) | 4.83B |